IFP Advisors’s KalVista Pharmaceuticals KALV Stock Holding History

IFP Advisors’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$189	Buy	+7	New	+$169	﹤0.01%	4864
2025 Q4	–	Sell	-5	Closed	-$61	–	4974
2025 Q3	$61	Buy	+5	New	+$69	﹤0.01%	4626
2025 Q2	–	Sell	-4	Closed	-$49	–	4439
2025 Q1	$46	Hold	4	–	–	﹤0.01%	4036
2024 Q4	$34	Buy	+4	New	+$41	﹤0.01%	4351

IFP Advisors's KALV Position: Q2 2026 in Review

IFP Advisors opened a new position in KalVista Pharmaceuticals (KALV) in Q2 2026: 7 shares worth $189. The stake represents ﹤0.01% of the portfolio and ranks #4864 among its holdings. This is a return to the name: IFP Advisors previously reported a position in KALV as recently as Q3 2025.

IFP Advisors first reported a position in KALV in Q4 2024 and has held it in 4 quarters since. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

IFP Advisors held 7 shares of KalVista Pharmaceuticals worth $189 as of Q2 2026.
KalVista Pharmaceuticals was a new IFP Advisors position in Q2 2026.
KalVista Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4864 holding.
IFP Advisors first reported a position in KalVista Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.